Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update

Bruno Martino, Philipp le Coutre, MD, Martin Griesshammer, MD, Thomas Illmer, MD, Rudolf Schlag, Cornelius F. Waller, MD, Anna Marina Liberati, Philippe Schafhausen, MD, Renato S Tavares, MD, Alessandro M. Vannucchi, MD, Pilar Giraldo, MD PhD, Lynda M Foltz, MD FRCP, Pia Raanani, MD, Vikas Gupta, MD FRCP, FRCPath, Bayane Tannir, Julian Perez Ronco, MD, Jaggannath Ghosh, Haifa Kathrin Al-Ali, MD

Blood (2014) 124 (21): 3197.

https://doi.org/10.1182/blood.V124.21.3197.3197

Published: 2014

Journal Articles

Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)

Martin Griesshammer, MD, Alessandro M. Vannucchi, MD, Philipp le Coutre, MD, Renato S Tavares, MD, Haifa Kathrin Al-Ali, MD, Pia Raanani, MD, Vikas Gupta, MD FRCP, FRCPath, Lynda M Foltz, MD FRCP, Pilar Giraldo, Catherine Bouard, Julian Perez Ronco, MD MBA, Jagannath Ghosh, Bruno Martino, MD

Blood (2014) 124 (21): 1859.

https://doi.org/10.1182/blood.V124.21.1859.1859

Published: 2014

Journal Articles

Safety and Efficacy of Ruxolitinib Retreatment after Treatment Interruption in Patients Enrolled in an Open-Label, Multicenter, Expanded-Access Study in Myelofibrosis

Vikas Gupta, MD FRCP, FRCPath, Renato S Tavares, MD, Martin Griesshammer, MD, Lynda M Foltz, MD FRCP, Pia Raanani, MD, Pilar Giraldo, Haifa Kathrin Al-Ali, MD, Bruno Martino, MD, Bayane Tannir, Julian Perez Ronco, MD, Jagannath Ghosh, Alessandro M. Vannucchi, MD

Blood (2014) 124 (21): 5567.

https://doi.org/10.1182/blood.V124.21.5567.5567

Published: 2014

Journal Articles

Should Albumin Be Considered a Prognostic Factor For Brazilian Patients Diagnosed With Classical Hodgkin Lymphoma

Guilherme Fleury Perini, MD, Egyla M Cavalcante, MD, Joao Garibaldi Rezende, Jr, MD, Davimar Miranda Borducchi, MD, Fernanda Cunha Vieira, Danielle Leao Cordeiro Faria, MD, Renato S Tavares, Fabio Pires de Souza Santos, MD, Nelson Hammershlack, MD, PhD, Karin Zattar Cecyn, Eni Maria Souza, M.D, PhD, Adriana M. Damasco Penna, M.D, Otavio C.G. Baiocchi, MD, PhD

Blood (2013) 122 (21): 5049.

https://doi.org/10.1182/blood.V122.21.5049.5049

Published: 2013

Journal Articles

Primary Myelofibrosis Brazilian Patient Journey: From Initial Symptoms To Treatment

Monika Conchon, MD, PhD, Renato S Tavares, MD, Katia B. Pagnano, MD, PhD, Tarcila S Datoguia, MD, Israel Bendit, MD, PhD, Marcia Torresan Delamain, MD, Irene Lorand-Metze, MD, PhD, Danielle Leão, MD, Jose Salvador Rodrigues, MD, PhD

Blood (2013) 122 (21): 5255.

https://doi.org/10.1182/blood.V122.21.5255.5255

Published: 2013

Journal Articles

Absolut Lymphocyte Count At Diagnosis Is Predictive Of Survival In Patients With Classical Hodgkin Lymphoma: A Retrospective Multicenter Brazilian Study

Guilherme Fleury Perini, MD, Egyla M Cavalcante, MD, Joao Garibaldi Rezende, Jr., MD, Davimar Miranda Borducchi, MD, Fernanda Cunha Vieira, MD, Danielle Leão Cordeiro Faria, MD, MS, Renato S Tavares, MD, Camila Almeida Amaral, Fabio S P Santos, MD, Nelson Hamerschlak, MD, PhD, Karin Zattar Cecyn, Eni Maria Souza, M.D, PhD, Adriana M. Damasco Penna, M.D, Otavio C.G. Baiocchi, MD, PhD

Blood (2013) 122 (21): 4236.

https://doi.org/10.1182/blood.V122.21.4236.4236

Published: 2013

Journal Articles

Epidemiological and Clinicopathological Data From the Brazilian Registry of Patients with Myelodysplastic Syndromes and Comparative Analysis Between Different Geographic Areas

Silvia M. M. Magalhaes, Tania Silva Madeira, Rosane Bittencourt, Elvira Velloso, Maria de Lourdes Chauffaille, Alita A Azevedo, Evandro M Fagundes, Maria Aparecida Zanichelli, Gloria Bonfim, Ligia N Melo, Renato S Tavares, Tereza Cristina Bortolheiro

Blood (2010) 116 (21): 1884.

https://doi.org/10.1182/blood.V116.21.1884.1884

Published: 2010

Journal Articles

Efficacy and Safety of Deferasirox (Exjade®) in Patients with Transfusion- Dependent Anemias: Preliminary Results From the First, Retrospective, Multicenter Brazilian Study.

Blood (2009) 114 (22): 5096.

https://doi.org/10.1182/blood.V114.22.5096.5096

Published: 2009

NARROW

Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update

Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)

Safety and Efficacy of Ruxolitinib Retreatment after Treatment Interruption in Patients Enrolled in an Open-Label, Multicenter, Expanded-Access Study in Myelofibrosis

Should Albumin Be Considered a Prognostic Factor For Brazilian Patients Diagnosed With Classical Hodgkin Lymphoma

Primary Myelofibrosis Brazilian Patient Journey: From Initial Symptoms To Treatment

Absolut Lymphocyte Count At Diagnosis Is Predictive Of Survival In Patients With Classical Hodgkin Lymphoma: A Retrospective Multicenter Brazilian Study

Epidemiological and Clinicopathological Data From the Brazilian Registry of Patients with Myelodysplastic Syndromes and Comparative Analysis Between Different Geographic Areas

Efficacy and Safety of Deferasirox (Exjade®) in Patients with Transfusion- Dependent Anemias: Preliminary Results From the First, Retrospective, Multicenter Brazilian Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only